Hyperhomocyst(e)inemia, but not methylenetetrahydrofolate reductase C677T mutation, as a risk factor in branch retinal vein occlusion
- 1 June 2002
- journal article
- Published by Elsevier in Ophthalmology
- Vol. 109 (6) , 1105-1109
- https://doi.org/10.1016/s0161-6420(02)01044-8
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Meta-analysis of Hyperhomocysteinemia as a Risk Factor for Venous Thromboembolic DiseaseArchives of internal medicine (1960), 1998
- Acute hyperhomocysteinaemia and endothelial dysfunctionThe Lancet, 1998
- Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action ProjectPublished by American Medical Association (AMA) ,1997
- Hyperhomocyst(e)inemia Is Associated With Impaired Endothelium-Dependent Vasodilation in HumansCirculation, 1997
- Hyperhomocysteinemia as a Risk Factor for Deep-Vein ThrombosisNew England Journal of Medicine, 1996
- Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor.Journal of Clinical Investigation, 1993
- Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen.Journal of Clinical Investigation, 1993
- Hyperhomocysteinemia: An Independent Risk Factor for Vascular DiseaseNew England Journal of Medicine, 1991
- Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cellsBlood, 1990
- Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator.Journal of Clinical Investigation, 1986